What is the first‑line therapy for acute conjunctivitis (pink eye)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Therapy for Pink Eye

For acute conjunctivitis, first-line therapy depends entirely on the etiology: viral conjunctivitis requires only supportive care with preservative-free artificial tears and cold compresses; bacterial conjunctivitis is treated with a 5-7 day course of broad-spectrum topical antibiotics such as polymyxin B/trimethoprim or fluoroquinolones; and allergic conjunctivitis responds to topical antihistamines with mast cell-stabilizing properties. 1

Diagnostic Approach to Determine Etiology

Before initiating treatment, you must distinguish between viral, bacterial, and allergic causes based on specific clinical features:

Viral Conjunctivitis (Most Common)

  • Watery discharge with a follicular reaction on the inferior tarsal conjunctiva 1
  • Preauricular lymphadenopathy, especially with adenoviral infections 1
  • Often starts unilateral but becomes sequentially bilateral within days 1
  • Concurrent upper respiratory symptoms (rhinorrhea, sore throat, fever) 1
  • Marked chemosis and eyelid swelling 1

Bacterial Conjunctivitis

  • Mucopurulent or purulent discharge with matted eyelids on waking 1, 2
  • Papillary (not follicular) conjunctival reaction 1
  • Absence of itching 1
  • May be unilateral or bilateral 1
  • Can be associated with concurrent otitis media, sinusitis, or pharyngitis in children 1

Allergic Conjunctivitis

  • Itching is the hallmark symptom and most consistent distinguishing feature 1, 2
  • Bilateral presentation 1
  • Watery discharge with mild mucous component 1
  • History of atopy, asthma, or eczema 1
  • Absence of preauricular lymphadenopathy 1

Treatment by Etiology

Viral Conjunctivitis (Self-Limited, Supportive Care Only)

Viral conjunctivitis requires no antibiotics—only supportive measures. 1

  • Preservative-free artificial tears four times daily to dilute viral particles and inflammatory mediators 1, 3
  • Cold compresses to reduce conjunctival swelling and improve comfort 1, 3
  • Avoid topical antibiotics entirely, as they provide no benefit and may cause toxicity 1, 3
  • Patient education about contagiousness: wash hands frequently, avoid sharing towels/pillows, minimize close contact for 10-14 days from symptom onset 1
  • Most cases resolve within 5-14 days without treatment 1

Critical pitfall: Indiscriminate use of topical corticosteroids can prolong adenoviral infections and exacerbate herpes simplex virus (HSV) keratitis. 1, 3 Never use steroids without first excluding HSV and ensuring close ophthalmology follow-up. 1

Bacterial Conjunctivitis (Topical Antibiotics)

For mild to moderate bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotics. 1, 3

First-Line Antibiotic Options

No single antibiotic has proven superiority, so choose based on convenience, cost, and local resistance patterns: 1, 3

  • Polymyxin B/trimethoprim drops four times daily 1, 4, 5

    • FDA-approved for acute bacterial conjunctivitis caused by S. aureus, S. epidermidis, S. pneumoniae, H. influenzae, and Pseudomonas aeruginosa 4
    • 95% cure or improvement rate within 7 days in pediatric studies 5
  • Erythromycin ointment 1

    • Often preferred in young children due to ease of application 1
  • Fluoroquinolones (moxifloxacin 0.5%, levofloxacin, gatifloxacin, ciprofloxacin) three to four times daily 1, 3

    • Fourth-generation agents (moxifloxacin) provide superior gram-positive coverage, including some MRSA strains 1, 3
    • Reserve for contact lens wearers due to Pseudomonas risk 3

Expected outcomes: Topical antibiotics shorten clinical disease duration (62% cured by days 3-5 vs. 28% with placebo) and enhance bacterial eradication (71% vs. 19% by days 3-5). 6, 3 This allows earlier return to work or school. 1

When to Obtain Cultures

  • Neonatal conjunctivitis (mandatory) 1
  • Suspected gonococcal infection (severe purulent discharge, marked lid edema) 1
  • Failure to improve after 5-7 days of appropriate therapy 1
  • Recurrent, severe, or chronic purulent conjunctivitis 1

Special Situations Requiring Systemic Antibiotics

Gonococcal conjunctivitis is a hyperacute, vision-threatening emergency requiring immediate systemic therapy: 7, 1

  • Ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g oral single dose 3
  • Daily ophthalmology follow-up until resolution 1, 3
  • Can cause corneal perforation within 24 hours if untreated 1, 3

Chlamydial conjunctivitis requires systemic treatment because >50% of infants have concurrent infection at other sites: 1, 3

  • Azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days 3
  • Evaluate and treat sexual partners 1, 3
  • Consider sexual abuse in preadolescent children 3

Allergic Conjunctivitis (Topical Antihistamines)

First-line treatment is topical antihistamines with mast cell-stabilizing properties. 1, 3

  • Olopatadine or ketotifen drops 1, 3
  • Adjunctive measures: cold compresses, refrigerated preservative-free artificial tears, sunglasses as allergen barrier 1, 3
  • Avoid eye rubbing 1
  • For refractory cases, consider a brief 1-2 week course of low-potency topical corticosteroids (fluorometholone, loteprednol) with IOP monitoring 1, 3

Red-Flag Findings Requiring Urgent Ophthalmology Referral

Do not treat empirically if any of the following are present—refer immediately: 1, 3

  • Visual loss or decreased vision 1
  • Moderate to severe pain (beyond mild irritation) 1
  • Corneal involvement (opacity, infiltrate, ulcer) 1
  • Severe purulent discharge suggesting gonococcal infection 1
  • Conjunctival scarring or pseudomembrane formation 1
  • History of HSV eye disease 1
  • Immunocompromised state 1
  • Recent ocular surgery or trauma 1
  • Contact lens wear with conjunctivitis (risk of bacterial keratitis) 1
  • Lack of response to therapy after 5-7 days 1

Common Pitfalls to Avoid

  • Never prescribe antibiotics for viral conjunctivitis—they cause unnecessary toxicity and promote resistance. 1, 3
  • Never use topical corticosteroids without excluding HSV and ensuring close ophthalmology follow-up, as they can exacerbate HSV infections, prolong adenoviral shedding, and cause elevated IOP and cataracts. 1, 3
  • Do not miss gonococcal conjunctivitis—it requires immediate systemic antibiotics and can cause corneal perforation. 1, 3
  • Avoid chronic use of topical vasoconstrictors—they cause rebound vasodilation. 3
  • Discard multi-dose eye drop containers if they contact the ocular surface to prevent cross-contamination. 1

Follow-Up Recommendations

  • Bacterial conjunctivitis: Return if no improvement in 3-4 days 1, 3
  • Viral conjunctivitis: Return if symptoms persist beyond 2-3 weeks or worsen 1
  • Gonococcal conjunctivitis: Daily visits until resolution 1, 3
  • Chlamydial conjunctivitis: Re-evaluate after treatment completion (19% failure rate) 3

References

Guideline

Clinical Presentation and Management of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.